Correlation Between Brompton European and Knight Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Brompton European and Knight Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Brompton European and Knight Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Brompton European Dividend and Knight Therapeutics, you can compare the effects of market volatilities on Brompton European and Knight Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Brompton European with a short position of Knight Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Brompton European and Knight Therapeutics.

Diversification Opportunities for Brompton European and Knight Therapeutics

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Brompton and Knight is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Brompton European Dividend and Knight Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Knight Therapeutics and Brompton European is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Brompton European Dividend are associated (or correlated) with Knight Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Knight Therapeutics has no effect on the direction of Brompton European i.e., Brompton European and Knight Therapeutics go up and down completely randomly.

Pair Corralation between Brompton European and Knight Therapeutics

Assuming the 90 days trading horizon Brompton European Dividend is expected to generate 0.55 times more return on investment than Knight Therapeutics. However, Brompton European Dividend is 1.83 times less risky than Knight Therapeutics. It trades about 0.0 of its potential returns per unit of risk. Knight Therapeutics is currently generating about -0.1 per unit of risk. If you would invest  1,075  in Brompton European Dividend on September 2, 2024 and sell it today you would lose (4.00) from holding Brompton European Dividend or give up 0.37% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Brompton European Dividend  vs.  Knight Therapeutics

 Performance 
       Timeline  
Brompton European 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Brompton European Dividend are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy basic indicators, Brompton European is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.
Knight Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Knight Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy fundamental indicators, Knight Therapeutics is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.

Brompton European and Knight Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Brompton European and Knight Therapeutics

The main advantage of trading using opposite Brompton European and Knight Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Brompton European position performs unexpectedly, Knight Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Knight Therapeutics will offset losses from the drop in Knight Therapeutics' long position.
The idea behind Brompton European Dividend and Knight Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.

Other Complementary Tools

Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
FinTech Suite
Use AI to screen and filter profitable investment opportunities